Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

285 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cell biology of the osteoclast.
Roodman GD. Roodman GD. Exp Hematol. 1999 Aug;27(8):1229-41. doi: 10.1016/s0301-472x(99)00061-2. Exp Hematol. 1999. PMID: 10428500 Review.
Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.
Rao H, Lu G, Kajiya H, Garcia-Palacios V, Kurihara N, Anderson J, Patrene K, Sheppard D, Blair HC, Windle JJ, Choi SJ, Roodman GD. Rao H, et al. J Bone Miner Res. 2006 Oct;21(10):1657-65. doi: 10.1359/jbmr.060718. J Bone Miner Res. 2006. PMID: 16995821 Free PMC article.
Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor.
Oba Y, Chung HY, Choi SJ, Roodman GD. Oba Y, et al. J Bone Miner Res. 2003 Jul;18(7):1332-41. doi: 10.1359/jbmr.2003.18.7.1332. J Bone Miner Res. 2003. PMID: 12854845
Annexin-2 is a regulator of stromal cell-derived factor-1/CXCL12 function in the hematopoietic stem cell endosteal niche.
Jung Y, Shiozawa Y, Wang J, Patel LR, Havens AM, Song J, Krebsbach PH, Roodman GD, Taichman RS. Jung Y, et al. Exp Hematol. 2011 Feb;39(2):151-166.e1. doi: 10.1016/j.exphem.2010.11.007. Epub 2010 Nov 22. Exp Hematol. 2011. PMID: 21108988 Free PMC article.
ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo.
Ishizuka H, GarcĂ­a-Palacios V, Lu G, Subler MA, Zhang H, Boykin CS, Choi SJ, Zhao L, Patrene K, Galson DL, Blair HC, Hadi TM, Windle JJ, Kurihara N, Roodman GD. Ishizuka H, et al. J Bone Miner Res. 2011 Jan;26(1):169-81. doi: 10.1002/jbmr.199. J Bone Miner Res. 2011. PMID: 20683884 Free PMC article.
Activating transcription factor 4 regulates osteoclast differentiation in mice.
Cao H, Yu S, Yao Z, Galson DL, Jiang Y, Zhang X, Fan J, Lu B, Guan Y, Luo M, Lai Y, Zhu Y, Kurihara N, Patrene K, Roodman GD, Xiao G. Cao H, et al. J Clin Invest. 2010 Aug;120(8):2755-66. doi: 10.1172/JCI42106. Epub 2010 Jul 12. J Clin Invest. 2010. PMID: 20628199 Free PMC article.
Pathophysiology of multiple myeloma bone disease.
Lentzsch S, Ehrlich LA, Roodman GD. Lentzsch S, et al. Hematol Oncol Clin North Am. 2007 Dec;21(6):1035-49, viii. doi: 10.1016/j.hoc.2007.08.009. Hematol Oncol Clin North Am. 2007. PMID: 17996587 Review.
Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expression.
Garcia-Palacios V, Chung HY, Choi SJ, Kurihara N, Lee JW, Ehrlich LA, Collins R, Roodman GD. Garcia-Palacios V, et al. Ann N Y Acad Sci. 2006 Apr;1068:240-3. doi: 10.1196/annals.1346.048. Ann N Y Acad Sci. 2006. PMID: 16831924
Regulation of osteoclast differentiation.
Roodman GD. Roodman GD. Ann N Y Acad Sci. 2006 Apr;1068:100-9. doi: 10.1196/annals.1346.013. Ann N Y Acad Sci. 2006. PMID: 16831910 Review.
Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.
Nguyen AN, Stebbins EG, Henson M, O'Young G, Choi SJ, Quon D, Damm D, Reddy M, Ma JY, Haghnazari E, Kapoun AM, Medicherla S, Protter A, Schreiner GF, Kurihara N, Anderson J, Roodman GD, Navas TA, Higgins LS. Nguyen AN, et al. Exp Cell Res. 2006 Jun 10;312(10):1909-23. doi: 10.1016/j.yexcr.2006.02.026. Epub 2006 Apr 4. Exp Cell Res. 2006. PMID: 16600214
285 results
Jump to page
Feedback